SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (155)8/16/1999 9:17:00 PM
From: Pseudo Biologist   of 427
 
Peter, yes (S) is (Short). Thanks for the analysis.

You are very right that we tend to be too gung-ho on the positives of the stuff we own, and are shy or scared (?) to focus too much, if at all, on the negatives. I guess many see these fora as bully pulpits or, in the words of the great Michael Burke, as stages for pis**ng matches.

Maybe it is my conservative(?) nature, but I look for negatives and discount positives in longs, and would do just the opposite in shorts. Examples include early stage products or secondary uses that may lead to off-label sales of a given candidate.

And thanks for the scoop on GELX and the reminder on PGNS; the latter a clear example that shorts some times do know what they are talking about. For a tragicomic recent example in a different context, take a look at IRID (or would it be IRIDQ now?).

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News